JI
Insider
John A Stalfort III
DirectorJohn A Stalfort III (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in VRCA. Across 1 priced purchase filing, the average 21-session return was -28.3% from execution and -34.0% from disclosure (delay-adjusted; derived). The largest single filing was $11.2M of VRCA (as filed, as filed), executed Nov 22 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-28.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-34.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$11.2M
shares × price, as filed
Last traded
Nov 22 2024
Filed Nov 26 2024
Volume by month
Buys $11.2M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
VRCA
VRCA
VRCA · 1 buy · 0 sells
1 filing
Recent filings
VRCAPURCHASE
Verrica Pharmaceuticals Inc.
View filing →
$11.2Mas filed
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET